FOXO1 (FKHR) Rearrangement Detection by FISH
GTR Test Accession: Help GTR000597222.1
CANCERINHERITED DISEASE
Registered in GTR: 2021-12-14
Last annual review date for the lab: 2024-06-14 LinkOut
At a Glance
Therapeutic management
Alveolar rhabdomyosarcoma
Genes (3): Help
FOXO1 (13q14.11); PAX3 (2q36.1); PAX7 (1p36.13)
Cytogenetics - FISH-metaphase: Fluorescence in situ hybridization (FISH)
Patients diagnosed with alveolar rhabdomyosarcoma (ARMS)
Not provided
Not provided
Ordering Information
Offered by: Help
Institute for Genomic Medicine (IGM) Clinical Laboratory
View lab's website
View lab's test page
Test short name: Help
FOXO1 FISH
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
  • Licensed Physician
  • Nurse Practitioner
Test Order Code: Help
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Samples can be accepted 7 days a week (Monday - Sunday). All samples must be labeled with minimum of two patient identifying information (e.g., Patient Name and Date of Birth). Please Submit disease involved sample with a completed requisition form and a pathology report documenting the diagnosis.
Order URL
Informed consent required: Help
No
Test strategy: Help
FOXO1 break apart FISH analysis performed. If positive, reflex to PAX3 fusion FISH will be performed next. If negative for PAX3-FOXO1 fusion, the PAX7 fusion FISH will be performed to evaluate for PAX7-FOXO1 fusion.
Pre-test genetic counseling required: Help
No
Post-test genetic counseling required: Help
No
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 3
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
FISH-metaphase
Fluorescence in situ hybridization (FISH)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Therapeutic management
Target population: Help
Patients diagnosed with alveolar rhabdomyosarcoma (ARMS)
Variant Interpretation:
Are family members with defined clinical status recruited to assess significance of VUS without charge? Help
No.

Will the lab re-contact the ordering physician if variant interpretation changes? Help
Not provided.
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
This assay detects >99% of FOXO1 gene fusion rearrangement present in tumor cells in sample that harbor this rearrangement if sample meets specimen requirement for specimen volume, quality, and sufficient % tumor content.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Intra-Laboratory
VUS:
Laboratory's policy on reporting novel variations Help
Unusual or clinically significant novel variants will be communicated to the ordering provider via telephone call or email communication.
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.